Lysosomal Storage Disease Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 69 pages | ID: L29E6217D416EN
Market Monitor Global

Abstracts

Lysosomal storage disease (LTD) is caused by defect in lysosomal functions and degradation pathway. It is caused by progressive accumulation of metabolites. LTD is a rare inherited metabolic disorder.

This report contains market size and forecasts of Lysosomal Storage Disease Treatment in Global, including the following market information:

Global Lysosomal Storage Disease Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Lysosomal Storage Disease Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Enzyme Replacement Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Lysosomal Storage Disease Treatment include Takeda, Pfizer, Sanofi, BioMarin, Merck, Actelion Pharmaceuticals and Eli Lilly, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Lysosomal Storage Disease Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Lysosomal Storage Disease Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Lysosomal Storage Disease Treatment Market Segment Percentages, by Type, 2021 (%)

• Enzyme Replacement Therapy
• Stem Cell Transplantation
• Substrate Reduction Therapy
• Others

Global Lysosomal Storage Disease Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Lysosomal Storage Disease Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Stem Transplant Centers
• Research Organizations
• Others

Global Lysosomal Storage Disease Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Lysosomal Storage Disease Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Lysosomal Storage Disease Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Lysosomal Storage Disease Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Takeda
• Pfizer
• Sanofi
• BioMarin
• Merck
• Actelion Pharmaceuticals
• Eli Lilly

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Lysosomal Storage Disease Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Lysosomal Storage Disease Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL LYSOSOMAL STORAGE DISEASE TREATMENT OVERALL MARKET SIZE

2.1 Global Lysosomal Storage Disease Treatment Market Size: 2021 VS 2028
2.2 Global Lysosomal Storage Disease Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Lysosomal Storage Disease Treatment Players in Global Market
3.2 Top Global Lysosomal Storage Disease Treatment Companies Ranked by Revenue
3.3 Global Lysosomal Storage Disease Treatment Revenue by Companies
3.4 Top 3 and Top 5 Lysosomal Storage Disease Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Lysosomal Storage Disease Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Lysosomal Storage Disease Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Lysosomal Storage Disease Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Lysosomal Storage Disease Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Lysosomal Storage Disease Treatment Market Size Markets, 2021 & 2028
  4.1.2 Enzyme Replacement Therapy
  4.1.3 Stem Cell Transplantation
  4.1.4 Substrate Reduction Therapy
  4.1.5 Others
4.2 By Type - Global Lysosomal Storage Disease Treatment Revenue & Forecasts
  4.2.1 By Type - Global Lysosomal Storage Disease Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Lysosomal Storage Disease Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Lysosomal Storage Disease Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Lysosomal Storage Disease Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Stem Transplant Centers
  5.1.5 Research Organizations
  5.1.6 Others
5.2 By Application - Global Lysosomal Storage Disease Treatment Revenue & Forecasts
  5.2.1 By Application - Global Lysosomal Storage Disease Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Lysosomal Storage Disease Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Lysosomal Storage Disease Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Lysosomal Storage Disease Treatment Market Size, 2021 & 2028
6.2 By Region - Global Lysosomal Storage Disease Treatment Revenue & Forecasts
  6.2.1 By Region - Global Lysosomal Storage Disease Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Lysosomal Storage Disease Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Lysosomal Storage Disease Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Lysosomal Storage Disease Treatment Revenue, 2017-2028
  6.3.2 US Lysosomal Storage Disease Treatment Market Size, 2017-2028
  6.3.3 Canada Lysosomal Storage Disease Treatment Market Size, 2017-2028
  6.3.4 Mexico Lysosomal Storage Disease Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Lysosomal Storage Disease Treatment Revenue, 2017-2028
  6.4.2 Germany Lysosomal Storage Disease Treatment Market Size, 2017-2028
  6.4.3 France Lysosomal Storage Disease Treatment Market Size, 2017-2028
  6.4.4 U.K. Lysosomal Storage Disease Treatment Market Size, 2017-2028
  6.4.5 Italy Lysosomal Storage Disease Treatment Market Size, 2017-2028
  6.4.6 Russia Lysosomal Storage Disease Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Lysosomal Storage Disease Treatment Market Size, 2017-2028
  6.4.8 Benelux Lysosomal Storage Disease Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Lysosomal Storage Disease Treatment Revenue, 2017-2028
  6.5.2 China Lysosomal Storage Disease Treatment Market Size, 2017-2028
  6.5.3 Japan Lysosomal Storage Disease Treatment Market Size, 2017-2028
  6.5.4 South Korea Lysosomal Storage Disease Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Lysosomal Storage Disease Treatment Market Size, 2017-2028
  6.5.6 India Lysosomal Storage Disease Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Lysosomal Storage Disease Treatment Revenue, 2017-2028
  6.6.2 Brazil Lysosomal Storage Disease Treatment Market Size, 2017-2028
  6.6.3 Argentina Lysosomal Storage Disease Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Lysosomal Storage Disease Treatment Revenue, 2017-2028
  6.7.2 Turkey Lysosomal Storage Disease Treatment Market Size, 2017-2028
  6.7.3 Israel Lysosomal Storage Disease Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Lysosomal Storage Disease Treatment Market Size, 2017-2028
  6.7.5 UAE Lysosomal Storage Disease Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Takeda
  7.1.1 Takeda Corporate Summary
  7.1.2 Takeda Business Overview
  7.1.3 Takeda Lysosomal Storage Disease Treatment Major Product Offerings
  7.1.4 Takeda Lysosomal Storage Disease Treatment Revenue in Global Market (2017-2022)
  7.1.5 Takeda Key News
7.2 Pfizer
  7.2.1 Pfizer Corporate Summary
  7.2.2 Pfizer Business Overview
  7.2.3 Pfizer Lysosomal Storage Disease Treatment Major Product Offerings
  7.2.4 Pfizer Lysosomal Storage Disease Treatment Revenue in Global Market (2017-2022)
  7.2.5 Pfizer Key News
7.3 Sanofi
  7.3.1 Sanofi Corporate Summary
  7.3.2 Sanofi Business Overview
  7.3.3 Sanofi Lysosomal Storage Disease Treatment Major Product Offerings
  7.3.4 Sanofi Lysosomal Storage Disease Treatment Revenue in Global Market (2017-2022)
  7.3.5 Sanofi Key News
7.4 BioMarin
  7.4.1 BioMarin Corporate Summary
  7.4.2 BioMarin Business Overview
  7.4.3 BioMarin Lysosomal Storage Disease Treatment Major Product Offerings
  7.4.4 BioMarin Lysosomal Storage Disease Treatment Revenue in Global Market (2017-2022)
  7.4.5 BioMarin Key News
7.5 Merck
  7.5.1 Merck Corporate Summary
  7.5.2 Merck Business Overview
  7.5.3 Merck Lysosomal Storage Disease Treatment Major Product Offerings
  7.5.4 Merck Lysosomal Storage Disease Treatment Revenue in Global Market (2017-2022)
  7.5.5 Merck Key News
7.6 Actelion Pharmaceuticals
  7.6.1 Actelion Pharmaceuticals Corporate Summary
  7.6.2 Actelion Pharmaceuticals Business Overview
  7.6.3 Actelion Pharmaceuticals Lysosomal Storage Disease Treatment Major Product Offerings
  7.6.4 Actelion Pharmaceuticals Lysosomal Storage Disease Treatment Revenue in Global Market (2017-2022)
  7.6.5 Actelion Pharmaceuticals Key News
7.7 Eli Lilly
  7.7.1 Eli Lilly Corporate Summary
  7.7.2 Eli Lilly Business Overview
  7.7.3 Eli Lilly Lysosomal Storage Disease Treatment Major Product Offerings
  7.7.4 Eli Lilly Lysosomal Storage Disease Treatment Revenue in Global Market (2017-2022)
  7.7.5 Eli Lilly Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Lysosomal Storage Disease Treatment Market Opportunities & Trends in Global Market
Table 2. Lysosomal Storage Disease Treatment Market Drivers in Global Market
Table 3. Lysosomal Storage Disease Treatment Market Restraints in Global Market
Table 4. Key Players of Lysosomal Storage Disease Treatment in Global Market
Table 5. Top Lysosomal Storage Disease Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Lysosomal Storage Disease Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Lysosomal Storage Disease Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Lysosomal Storage Disease Treatment Product Type
Table 9. List of Global Tier 1 Lysosomal Storage Disease Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Lysosomal Storage Disease Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Lysosomal Storage Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Lysosomal Storage Disease Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Lysosomal Storage Disease Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Lysosomal Storage Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Lysosomal Storage Disease Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Lysosomal Storage Disease Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Lysosomal Storage Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Lysosomal Storage Disease Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Lysosomal Storage Disease Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Lysosomal Storage Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Lysosomal Storage Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Lysosomal Storage Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Lysosomal Storage Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Lysosomal Storage Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Lysosomal Storage Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Lysosomal Storage Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Lysosomal Storage Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Lysosomal Storage Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Lysosomal Storage Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Takeda Corporate Summary
Table 31. Takeda Lysosomal Storage Disease Treatment Product Offerings
Table 32. Takeda Lysosomal Storage Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Lysosomal Storage Disease Treatment Product Offerings
Table 35. Pfizer Lysosomal Storage Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Sanofi Corporate Summary
Table 37. Sanofi Lysosomal Storage Disease Treatment Product Offerings
Table 38. Sanofi Lysosomal Storage Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 39. BioMarin Corporate Summary
Table 40. BioMarin Lysosomal Storage Disease Treatment Product Offerings
Table 41. BioMarin Lysosomal Storage Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Merck Corporate Summary
Table 43. Merck Lysosomal Storage Disease Treatment Product Offerings
Table 44. Merck Lysosomal Storage Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Actelion Pharmaceuticals Corporate Summary
Table 46. Actelion Pharmaceuticals Lysosomal Storage Disease Treatment Product Offerings
Table 47. Actelion Pharmaceuticals Lysosomal Storage Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Eli Lilly Corporate Summary
Table 49. Eli Lilly Lysosomal Storage Disease Treatment Product Offerings
Table 50. Eli Lilly Lysosomal Storage Disease Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Lysosomal Storage Disease Treatment Segment by Type in 2021
Figure 2. Lysosomal Storage Disease Treatment Segment by Application in 2021
Figure 3. Global Lysosomal Storage Disease Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Lysosomal Storage Disease Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Lysosomal Storage Disease Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Lysosomal Storage Disease Treatment Revenue in 2021
Figure 8. By Type - Global Lysosomal Storage Disease Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Lysosomal Storage Disease Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Lysosomal Storage Disease Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Lysosomal Storage Disease Treatment Revenue Market Share, 2017-2028
Figure 12. US Lysosomal Storage Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Lysosomal Storage Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Lysosomal Storage Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Lysosomal Storage Disease Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Lysosomal Storage Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Lysosomal Storage Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Lysosomal Storage Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Lysosomal Storage Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Lysosomal Storage Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Lysosomal Storage Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Lysosomal Storage Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Lysosomal Storage Disease Treatment Revenue Market Share, 2017-2028
Figure 24. China Lysosomal Storage Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Lysosomal Storage Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Lysosomal Storage Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Lysosomal Storage Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Lysosomal Storage Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Lysosomal Storage Disease Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Lysosomal Storage Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Lysosomal Storage Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Lysosomal Storage Disease Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Lysosomal Storage Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Lysosomal Storage Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Lysosomal Storage Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Lysosomal Storage Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Takeda Lysosomal Storage Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pfizer Lysosomal Storage Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Sanofi Lysosomal Storage Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. BioMarin Lysosomal Storage Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Merck Lysosomal Storage Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Actelion Pharmaceuticals Lysosomal Storage Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Eli Lilly Lysosomal Storage Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)